Trial · NCT05108935
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion who demonstrate no or minimal opioid use. | 3 months | Defined as self-reported opioid use on ≤4 days in the past month and/or 2 or more consecutive negative urine tests. |
| Primary | Proportion who demonstrate no or minimal opioid use. | 6 months | Defined as self-reported opioid use on ≤4 days in the past month and/or 2 or more consecutive negative urine tests. |
| Primary | Proportion who remain HIV negative. | 3 months | Measured via negative HIV test. |
| Primary | Proportion who remain HIV negative. | 6 months | Measured via negative HIV test. |
| Primary | Among participants who undergo hepatitis C treatment, the hepatitis C cure rate | 6 months | Measured via negative hepatitis C test. |
| Primary | Persistence in care | 3 months | Defined as the proportion who remain on treatment. |
| Primary | Persistence in care | 6 months | Defined as the proportion who remain on treatment. |
| Primary | Ease/difficulty of visiting a SSP to meet with a provider via telemedicine | month 1 | Exploratory method, conducted in the form of individual interviews to document the personal experiences of each participant (qualitative method) |
| Primary | Ease/difficulty of visiting a SSP to meet with a provider via telemedicine | month 6 | Exploratory method, conducted in the form of individual interviews to document the personal experiences of each participant (qualitative method) |
| Primary | Ease/difficulty of accessing the telemedicine video platform | month 1 | Exploratory method, conducted in the form of individual interviews to document the personal experiences of each participant (qualitative method) |
| Primary | Acceptability of medical care via a telemedicine video platform | 6 month | Exploratory method, conducted in the form of individual interviews to document the personal experiences of each participant (qualitative method) |
| Primary | Participant satisfaction with the program | 1 month | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant (qualitative method) |
| Primary | Participant satisfaction with the program | month 6 | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant over time (qualitative method) |
| Primary | Participant perceived usefulness of the program | month 1 | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant (qualitative method) |
| Primary | Participant perceived usefulness of the program | month 6 | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant (qualitative method) |
| Primary | Motivators and barriers affecting program persistence | month 6 | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant over time (qualitative method) |
| Primary | Motivators and barriers affecting medication adherence and persistence | 6 months | Exploratory method, conducted in the form of individual interviews to document the personal experiences and opinions of each participant over time (qualitative method) |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05108935/registered